Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

OBJECTIVE: To assess the safety and efficacy of etoricoxib, a selective cyclo-oxygenase-2 inhibitor, in comparison with indometacin in the treatment of acute gouty arthritis. DESIGN: Randomised, double blind, active comparator controlled trial. SETTING: 43 outpatient study centres in 11 countries. P...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	BMJ
Autori principali:	Schumacher, H Ralph, Boice, Judith A, Daikh, David I, Mukhopadhyay, Saurabh, Malmstrom, Kerstin, Ng, Jennifer, Tate, Guillermo A, Molina, Javier
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMJ Publishing Group 2002
Soggetti:	Papers
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC116444/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12077033/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.324.7352.1488
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!